WISP 1 is an important survival factor in human mesenchymal stromal cells

Gene

Volumn 551, Issue 2, 2014, Pages 243-254

  Schlegelmilch, Katrin ^a   Keller, Alexander ^a   Zehe, Viola ^a   Hondke, Sylvia ^a   Schilling, Tatjana ^a   Jakob, Franz ^a   Klein Hitpass, Ludger ^b   Schütze, Norbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Apoptosis; Cancer; Death receptors; Human stem cell; Musculoskeletal system; TRAIL; WNT signalling

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; LIPOCORTIN 5; PROTEIN; RNA DIRECTED DNA POLYMERASE; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND 1; UNCLASSIFIED DRUG; WISP 1 PROTEIN; CCN PROTEIN; HYDROGEN PEROXIDE; ONCOPROTEIN; OXIDIZING AGENT; WISP1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL FACTOR; WNT SIGNALING PATHWAY; AGED; CELL CULTURE; CELL SURVIVAL; CONFOCAL MICROSCOPY; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; RNA INTERFERENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOPTOSIS; CCN INTERCELLULAR SIGNALING PROTEINS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HEK293 CELLS; HUMANS; HYDROGEN PEROXIDE; MESENCHYMAL STROMAL CELLS; MICROSCOPY, CONFOCAL; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDANTS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84908463544     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.09.002     Document Type: Article

References (55)

1. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., et al. Gene ontology: tool for the unification of biology. Nat. Genet. 2000, 25:25.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 1995, 289-300.
3. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996, 85:803-815.
4. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993, 327:125-130.
5. Brigstock D.R., Goldschmeding R., K-i Katsube, Lam S.C.-T., Lau L.F., et al. Proposal for a unified CCN nomenclature. Mol. Pathol. 2003, 56:127-128.
6. Carlson M., Falcon S., Pages H., Li N. hgu133plus2.db: affymetrix human genome U133 Plus 2.0 array annotation data (chip hgu133plus2) 2012.
7. Carlson M., Falcon S., Pages H., Li N. GO.db: A Set of Annotation Maps Describing the Entire Gene Ontology 2012.
8. Chong H.C., Tan C.K., Huang R.L., Tan N.S. Matricellular proteins: a sticky affair with cancers. J. Oncol. 2012, 2012:351089.
9. Cory S., Adams J.M., et al. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2:647-656.
10. Falcon S., Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23:257.
11. French D.M., Kaul R.J., D'Souza A.L., Crowley C.W., Bao M., et al. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am. J. Pathol. 2004, 165:855-867.
12. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
13. Gentleman R. Annotate: Annotation for Microarrays 2012.
14. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
15. Gentleman R., Carey V., Huber W., Hahne F. Genefilter: Methods for Filtering Genes From Microarray Experiments 2012.
16. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998, 12:2973-2983.
17. Gruss H.J., Dower S.K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995, 85:3378-3404.
18. Harris M.A., Clark J., Ireland A., Lomax J., Ashburner M., et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004, 32:D258.
19. Haynesworth S., Goshima J., Goldberg V., Caplan A. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
20. Holloway S.E., Beck A.W., Girard L., Jaber M.R., Barnett C.C., et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J. Am. Coll. Surg. 2005, 200:371-377.
21. Inkson C.A., Ono M., Kuznetsov S.A., Fisher L.W., Robey P.G., et al. TGF-β1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J. Cell. Biochem. 2008, 104:1865-1878.
22. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26:239-257.
23. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 2000, 6:513-519.
24. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 1999, 248:44-57.
25. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
26. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
27. Nakanishi T., Nishida T., Shimo T., Kobayashi K., Kubo T., et al. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 2000, 141:264-273.
28. Nöth U., Tuli R., Osyczka A.M., Danielson K.G., Tuan R.S. In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng. 2002, 8:131-144.
29. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999, 27:29.
30. Parisi M.S., Gazzerro E., Rydziel S., Canalis E. Expression and regulation of CCN genes in murine osteoblasts. Bone 2006, 38:671-677.
31. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14717-14722.
32. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol. Pathol. 2001, 54:57-79. (MP).
33. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004, 363:62-64.
34. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
35. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., et al. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 2002, 4:842-849.
36. Schuetze N., Noeth U., Schneidereit J., Hendrich C., Jakob F. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun. Signal. 2005, 3:5.
37. Secchiero P., Melloni E., Corallini F., Beltrami A.P., Alviano F., et al. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells 2008, 26:2955-2963.
38. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277:818-821.
39. Shikama N., Lee C.W., France S., Delavaine L., Lyon J., et al. A novel cofactor for p300 that regulates the p53 response. Mol. Cell 1999, 4:365-376.
40. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (Eds.).
41. Su F., Overholtzer M., Besser D., Levine A.J. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev. 2002, 16:46-57.
42. Szegezdi E., O'Reilly A., Davy Y., Vawda R., Taylor D.L., et al. Stem cells are resistant to TRAIL receptor-mediated apoptosis. J. Cell. Mol. Med. 2009, 13:4409-4414.
43. Tanaka S., Sugimachi K., Saeki H., Kinoshita J., Ohga T., et al. A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene 2001, 20:5525-5532.
44. Team RDC R: A Language and Environment for Statistical Computing 2010, R Foundation for Statistical Computing, Vienna Austria.
45. Thomadaki H., Scorilas A. BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit. Rev. Clin. Lab. Sci. 2006, 43:1-67.
46. Venkatesan B., Prabhu S.D., Venkatachalam K., Mummidi S., Valente A.J., et al. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell. Signal. 2010, 22:809-820.
47. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 1999, 5:157-163.
48. Warnes G.R. gplots: Various R Programming Tools for Plotting Data 2010.
49. Wu G.S., Burns T.F., McDonald E.R., Jiang W., Meng R., et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 1997, 17:141-143.
50. Xu L., Corcoran R.B., Welsh J.W., Pennica D., Levine A.J. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev. 2000, 14:585-595.
51. Yanagita T., Kubota S., Kawaki H., Kawata K., Kondo S., et al. Expression and physiological role of CCN4/Wnt-induced secreted protein mRNA splicing variants in chondrocytes. FEBS J. 2007, 274:1655-1665.
52. Zemans R.L., McClendon J., Aschner Y., Briones N., Young S.K., et al. Role of β-catenin-regulated CCN matricellular proteins in epithelial repair after inflammatory lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 304:L415-L427.
53. Zhang J.D., Wiemann S. KEGGgraph: KEGGgraph: A Graph Approach to KEGG PATHWAY in R and Bioconductor 2010.
54. Zhang Y., Pan Q., Zhong H., Merajver S.D., Kleer C.G. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res. 2005, 7:R1080-R1089.
55. Zhong X., Rescorla F.J. Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell. Signal. 2012, 24:393-401.